Figure 4.
Effects of CD73, APCP and Ado on DRG neurons in hypoxic and hypoglycemic environments. (A) The extracellular Ado concentration in CD73-/- and CD73 DRG neurons. (B) The Ado concentration in the spinal cord of CD73-/- and WT mice. (C) The expression of apoptosis-related genes and PKA/CREB signaling pathway genes in CD73- and APCP-treated mouse DRG neurons under oxygen-glucose deprivation. (D) The content of cAMP in CD73- and APCP-treated mouse DRG neurons under oxygen-glucose deprivation. (E) The expression of apoptosis-related genes and PKA/CREB signaling pathway genes in CD73-/-- and Ado-treated mouse DRG neurons under oxygen-glucose deprivation. (F) The content of cAMP in CD73-/-- and Ado-treated mouse DRG neurons under oxygen-glucose deprivation. *P<0.05, **P<0.01 and ***P<0.001. CD73, ecto-5'-nucleotidase; APCP, α,β-methylene ADP; Ado, adenosine; DRG, dorsal root ganglion; WT, wild-type; PKA/CREB, protein kinase A/cAMP response element-binding protein; NC, negative control.